Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder

Ähnliche Einträge

• A case of reinitiation of modified electroconvulsive therapy 2 weeks after modified electroconvulsive therapy‐induced Takotsubo cardiomyopathy in a male patient with major depressive disorder
  von: Dai Kezuka, et al.
  Veröffentlicht: (2024)
• Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder
  von: Aleena Francis, et al.
  Veröffentlicht: (2026)
• Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
  von: Yasmin Esmaeilian, et al.
  Veröffentlicht: (2026)
• A case report of ineffective electroconvulsive therapy for chronic pain
  von: Takashi Fukao, et al.
  Veröffentlicht: (2025)
• Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
  von: Alexander A. Yakovlev
  Veröffentlicht: (2024)